Circulation, Vol 81, 1457-1476, Copyright © 1990 by American Heart Association
WJ Rogers, DS Baim, JM Gore, BG Brown, R Roberts, DO Williams, JH Chesebro, JD Babb, FH Sheehan and FJ Wackers
To assess the value and timing of percutaneous transluminal coronary
angioplasty (PTCA) after thrombolytic therapy for acute myocardial
infarction (AMI), 586 patients in the Thrombolysis in Myocardial Infarction
Study Phase II-A were randomized among three treatment strategies, one
using immediate coronary arteriography followed by PTCA if appropriate
(immediate invasive strategy group, n = 195), a second that deferred
angiography and PTCA for 18-48 hours (delayed invasive strategy group, n =
194), and a third, more conservative, approach in which PTCA was used only
if ischemia occurred spontaneously or at the time of predischarge exercise
testing (conservative strategy group, n = 197). Predischarge contrast left
ventricular ejection fraction, the primary study end point, was similar
among the patients in all three treatment groups and averaged 49.3%. The
finding of a patent infarct- related artery at the time of predischarge
arteriography was equally common among the patients in the three groups
(mean, 83.7%); however, the mean residual infarct artery stenosis was
greater in the patients in the conservative strategy group (67.2%) as
compared with the patients in the immediate invasive (50.6%) and the
delayed invasive strategy groups (47.8%) (p less than 0.001). Immediate
invasive strategy led to a higher rate of coronary artery bypass graft
surgery (CABG) after PTCA (7.7%) than did delayed invasive and conservative
strategies (2.1% and 2.5%, respectively; p less than 0.01). Furthermore,
among patients not undergoing CABG during the first 21 days, blood
transfusion of more than 1 unit was used in 13.8% of the patients in the
immediate invasive strategy group, 3.1% of the patients in the delayed
invasive strategy group, and 2.0% of the patients in the conservative
strategy group (p less than 0.001). At 1-year follow-up, the three
treatment groups had similar cumulative rates of mortality (8.7%, pooled
over all groups), fatal and nonfatal reinfarction (8.5%), combined death
and reinfarction (14.5%), and CABG (17.2%), although the cumulative
performance rate of PTCA remained higher in the invasive groups (immediate
invasive strategy group, 75.8%; delayed invasive strategy group, 64.3%; and
conservative strategy group, 23.9%; p less than 0.001). Thus, because
conservative strategy achieves equally good short- and long-term outcome
with less morbidity and a lower use of PTCA, it seems to be the preferred
initial management strategy.
ARTICLES
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial
Thrombolysis in Myocardial Infarction, Coordinating Center, Baltimore, Maryland.
This article has been cited by other articles:
![]() |
G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions Circulation, July 29, 2008; 118(5): 552 - 566. [Full Text] [PDF] |
||||
![]() |
M. L. Brown, T. M. Sundt III, and B. J. Gersh Indications for Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572. [Full Text] |
||||
![]() |
I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text] |
||||
![]() |
T. J. Kiernan, H. H. Ting, and B. J. Gersh Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls Eur. Heart J., July 1, 2007; 28(13): 1545 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Collet, G. Montalescot, M. Le May, M. Borentain, and A. Gershlick Percutaneous Coronary Intervention After Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1326 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Cantor, F. Brunet, C. P. Ziegler, A. Kiss, and L. J. Morrison Immediate angioplasty after thrombolysis: a systematic review Can. Med. Assoc. J., December 6, 2005; 173(12): 1473 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Beygui and G. Montalescot The use of GP IIb/IIIa inhibitors into new perspectives: pre-catheterization laboratory administration Eur. Heart J. Suppl., October 1, 2005; 7(suppl_I): I10 - I14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Le May, G. A. Wells, M. Labinaz, R. F. Davies, M. Turek, D. Leddy, J. Maloney, T. McKibbin, B. Quinn, R. S. Beanlands, et al. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study) J. Am. Coll. Cardiol., August 2, 2005; 46(3): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gersh, G. W. Stone, H. D. White, and D. R. Holmes Jr Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future? JAMA, February 23, 2005; 293(8): 979 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schomig, G. Ndrepepa, J. Mehilli, J. Dirschinger, S. G. Nekolla, C. Schmitt, S. Martinoff, M. Seyfarth, M. Schwaiger, A. Kastrati, et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2073 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Dauerman and B. E. Sobel Synergistic treatment of ST-segmentelevation myocardial infarction with pharmacoinvasive recanalization J. Am. Coll. Cardiol., August 20, 2003; 42(4): 646 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. O'Neill "Watchful waiting"after thrombolysis: It's time for a re-evaluation J. Am. Coll. Cardiol., July 2, 2003; 42(1): 17 - 19. [Full Text] [PDF] |
||||
![]() |
T. M. Sundt III, B. J. Gersh, and H. C. Smith Indications for Coronary Revascularization Card. Surg. Adult, January 1, 2003; 2(2003): 541 - 559. [Full Text] |
||||
![]() |
D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658. [Full Text] |
||||
![]() |
L. Pilote, C. Lauzon, T. Huynh, D. Dion, R. Roux, N. Racine, S. Carignan, J. G. Diodati, C. Levesque, F. Charbonneau, et al. Quality of Life After Acute Myocardial Infarction Among Patients Treated at Sites With and Without On-site Availability of Angiography Arch Intern Med, March 11, 2002; 162(5): 553 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF] |
||||
![]() |
L. E. Goldman and M. J. Eisenberg Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction Ann Intern Med, April 4, 2000; 132(7): 556 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Rogers, J. G. Canto, H. V. Barron, J. A. Boscarino, D. A. Shoultz, N. R. Every, and for the Investigators in the National Registry of Treatment and outcome of myocardial infarction in hospitals with and without invasive capability J. Am. Coll. Cardiol., February 1, 2000; 35(2): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, R. M. Califf, T. D. Thompson, J. S. Hochman, E. M. Ohman, M. Pfisterer, E. R. Bates, A. Vahanian, P. W. Armstrong, D. A. Criger, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction J. Am. Coll. Cardiol., January 1, 2000; 35(1): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1756 - 1824. [Full Text] [PDF] |
||||
![]() |
M. Previtali, R. Fetiveau, L. Lanzarini, C. Cavalotti, and C. Klersy Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis J. Am. Coll. Cardiol., August 1, 1998; 32(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pilote, D. P. Miller, R. M. Califf, J. S. Rao, W. D. Weaver, and E. J. Topol Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction N. Engl. J. Med., October 17, 1996; 335(16): 1198 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lanzkron and W. R. Bell State-of-the-Art Review : Management of Patients Who Require Invasive Procedures Immediately Following Thrombolytic Therapy Clinical and Applied Thrombosis/Hemostasis, July 1, 1996; 2(3): 158 - 163. [Abstract] [PDF] |
||||
![]() |
L. Pilote, R. M. Califf, S. Sapp, D. P. Miller, D. B. Mark, W. D. Weaver, J. M. Gore, P. W. Armstrong, E. M. Ohman, E. J. Topol, et al. Regional Variation across the United States in the Management of Acute Myocardial Infarction N. Engl. J. Med., August 31, 1995; 333(9): 565 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Michels and S. Yusuf Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates? : A Quantitative Overview (Meta-Analysis) of the Randomized Clinical Trials Circulation, January 15, 1995; 91(2): 476 - 485. [Abstract] [Full Text] |
||||
![]() |
C. L. Grines, K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 673 - 679. [Abstract] [Full Text] |
||||
![]() |
H. Tomoda Electrocardiographic Prediction of the Success of Coronary Reperfusion by Intravenous Thrombolytic Therapy: An Experimental Study Angiology, August 1, 1992; 43(8): 631 - 640. [Abstract] [PDF] |
||||
![]() |
MORE SUPPORT FOR CONSERVATIVE MANAGEMENT AFTER THROMBOLYSIS Journal Watch (General), May 22, 1990; 1990(522): 2 - 2. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |